Greater China-focused private equity firm Ascendent Capital Partners has invested RMB50 million ($7.34 million) in BioChain Beijing, a subsidiary of integrated bio and data technology firm Team Curis Group with labs in China and the US.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
